Summary
A family of compounds which appear to bind reversibly to double stranded DNA without intercalation between DNA base pairs has been defined. Methods are described by which this non-intercalative binding can be characterised using ultraviolet spectrometry, fluorimetry with ethidium as a probe, viscometry and other hydrodynamic techniques, circular dichroism and nuclear magnetic resonance spectrometry. Antibiotics which fall into this family include the antibiotics distamycin A, netropsin, mithramycin, chromomycin and olivomycin. Synthetic antitumour agents include diarylamidines such as berenil, phthalanilides, aromatic bisguanylhydrazones and bisquaternary ammonium heterocycles. A survey has been made of the general requirements of this family of compounds for DNA binding and biological activity. Binding of drugs to the minor groove of the DNA double helix appears to be the most likely mechanism for the antitumour action of these compounds.
Similar content being viewed by others
References
Zimmer, C., 1975. Prog. Nucleic Acid Res. Mol. Biol. 15: 285–318.
Braithwaite, A. W. & Baguley, B. C., 1980. Biochemistry 19: 1101–1106.
Waring, M. J., 1965. J. Mol. Biol. 13: 269–282.
Sobell, H. M., Tsai, C.-C., Jain, S. C. & Gilbert, S. G., 1977. J. Mol. Biol. 114: 333–365.
Blake, A. & Peacocke, A. R., 1968. Biopolymers 6: 1225–1253.
Müller, W. & Gautier, 1978. Eur. J. Biochem. 54: 385–394.
Müller, W., Crothers, D. M. & Waring, M. J., 1973. Eur. J. Biochem. 39: 223–234.
Le Pecq, J.-B. & Paoletti, C., 1967. J. Mol. Biol. 27: 87–106.
Hahn, F. E., 1975. In: Antibiotics—III. Mechanism of Action of Antimicrobial and Antitumor Agents (Corcoran, J. W. & Hahn, F. E. eds), pp. 79–100, Springer Verlag, Berlin.
Baguley, B. C. & Falkenhaug, E.-M., 1978. Nucleic Acids Res. 5: 161–171.
Cain, B. F., Baguley, B. C. & Denny, W. A., 1978. J. Med. Chem. 21: 658–668.
Baguley, B. C., Denny, W. A., Atwell, G. J. & Cain, B. F., 1981. J. Med. Chem. 24: 170–177.
McGhee, J. D. & von Hippel, P. H., 1974. J. Mol. Biol. 86: 469–489.
Arnett, S., Bond, P. J. & Chandrasekaram, R., 1980. Nature 287: 561–563.
Waring, M. J., 1981. Ann. Rev. Biochem. 50: 159–192.
Bauer, W. R., 1978. Ann. Rev. Biophys. Bioeng. 7: 287–331.
Revet, B. M., Schmir, M. & Vinograd, J., 1971. Nature (London), New Biol. 229: 10–13.
Dalgleish, D. G., Feil, M. C. & Peacocke, A. R., 1972. Biopolymers 11: 2415–2422.
Dalgleish, D. G., Peacocke, A. R., Fey, G. & Harve, G., 1971. Biopolymers 10: 1853–1863.
Dalgleish, D. G., Fey, G. & Kersten, H., 1974. Biopolymers 13: 1757–1766.
Zimmer, C., 1980. Biochim. Biophys. Acta 607: 232–246.
Michenkova, L. & Zimmer, C., 1980. Biopolymers 19: 823–831.
Patel, D. J., 1979. Accounts Chem. Res. 12: 118–125.
Phillips, D. R. & Roberts, G. C. K., 1980. Biochemistry 19: 4795–4801.
Patel, D. J. & Canuel, L. L., 1977. Proc. Natl. Acad. Sci. U.S.A. 74: 5207–5211.
Patel, D. J. & Canuel, L. L., 1979. Proc. Natl. Acad. Sci. U.S.A. 76: 24–28.
Patel, D., 1980. In: Nucleic Acid Geometry and Dynamics, (Sarma, R. H., ed), pp. 185–231, Permagon Press, New York.
Hahn, F. E., 1980. Antibiot. Chemother. 27: 70–92.
Krey, A. K., 1980. Prog. Mol. Subcell. Biol. 7: 43–87.
Bialer, M., Yagen, B., Mechoulam, R. & Becker, Y., 1980. J. Med. Chem. 23: 1144–1148.
Berman, H. M., Neidle, S., Zimmer, C. & Thrum, H., 1979. Biochim. Biophys. Acta 561: 124–131.
Gurskaya, G. V., Grokhovsky, S. L., Zhuze, A. L. & Gottikh, B. P., 1979. Biochim. Biophys. Acta 563: 336–342.
Mackenzie, A. R., 1966. Cancer 19: 1369–1376.
Slavic, M. & Carter, S. K., 1975. Adv. Pharmacol. Chemother. 12: 1–30.
Gause, G. F., 1975. In: Antibiotics—III. Mechanism of Action of Antimicrobial and Antitumor Agents (Corcoran, J. W. & Hahn, F. E., eds), pp. 197–202, Springer Verlag, Berlin.
Kersten, H. & Kersten, W., 1974. In: Inhibitors of Nucleic Acid Synthesis: Biophysical and Biochemical Aspects. Molecular Biology, Biochemistry and Biophysics (Kleinzeller, A., Springer, G. F. & Wittman, H. G. eds), vol. 18, pp. 86–96, Springer Verlag, Berlin.
Behr, W., Honikel, K. & Hartmann, G., 1969. Eur. J. Biochem. 9: 82–92.
Waring, M. J., 1971. Prog. Mol. Subcell. Biol. 2: 215–229.
Ward, D., Reich, E. & Goldberg, I. H., 1965. Science 149: 1259–1273.
Kumar, V., Remers, W. A. & Bradner, W. T., 1980. J. Med. Chem. 23: 376–379.
Newton, B. A., 1975. In: Antibiotics—III. Mechanism of Action of Antimicrobial and Antitumor Agents (Corcoran, J. W. & Hahn, F. E. eds), pp. 34–47, Springer Verlag, Berlin.
Cain, B. F., Atwell, G. J. & Seelye, R. N., 1969. J. Med. Chem. 12: 199–206.
Snapper, I., 1948. J. Am. Med. Ass. 137: 513–516.
Jensch, H., 1958. Med. Chem. 6: 134–169.
Bennett, L. L. Jr., 1965. Prog. Exp. Tumor Res. 7: 259–325.
Anné, J., De Clerq, E., Eyssen, H. & Dann, O., 1980. Antimicrob. Agents Chemother. 18: 231–239.
De Clerq, E. & Dann, O., 1980. J. Med. Chem. 23: 787–795.
Hirt, R. & Berchtold, R., 1969. Experientia 17: 418–420.
Yesair, D. W. & Kensler, C. J., 1975. In: Handbook of Experimental Pharmacology: Antineoplastic and Immunesuppressive Agents (Brodie, B. B. & Gillette, J. R., eds), vol 38, part 2, pp. 820–828, Springer Verlag, Berlin.
Sivak, A., Rogers, W. I., Wodinsky, I. & Kensler, C. J., 1965. Cancer Res. 25: 902–909.
Rauen, H. M., Norpoth, K., Unterberg, W. & Haar, H., 1965. Experientia 21: 300–304.
Yesair, D. W., Kohner, F. A., Rogers, W. I., Baronwsky, P. E. & Kensler, C. J., 1966. Cancer Res. 26: 202–207.
Yesair, D. W., Rogers, W. I., Funkhouser, J. T. & Kensler, C. J., 1966. J. Lipid Res. 7: 492–500.
Marxer, A., 1967. Experientia 23: 173–174.
Mihich, E. & Gelzer, J., 1968. Cancer Res. 28: 553–558.
Mihich, E., 1975. In: Handbook of Experimental Pharmacology: Antineoplastic and Immunosuppressive Agents (Brodie, B. B. & Gillette, J. R., eds), vol. 38, part 2, pp. 766–788, Springer Verlag, Berlin.
Dave, C., Ehrke, M. J. & Mihich, E., 1977. Chem. Biol. Interact. 16: 57–68.
Denny, W. A. & Cain, B. F., 1979. J. Med. Chem. 22: 1234–1239.
Regelson, W. & Holland, J. F., 1963. Cancer Chemother. Rep. 27: 15–26.
Knight, W. A., Livingston, R. B., Fabian, C. & Constanzi, J., 1979. Proc. Am. Assoc. Cancer Res. 20: 319.
Williams-Ashman, H. G. & Schenone, A., 1972. Biochem. Biophys. Res. Commun. 46: 288–295.
Corti, A., Dave, C., Williams-Ashman, H. G., Mihich, E. & Schenone, A., 1974. Biochem. J. 139: 351–357.
Janne, J., Poso, H. & Raina, A., 1978. Biochem. Biophys. Acta 473: 241–293.
Pine, M. J. & Di Paolo, J., 1966. Cancer Res. 26: 18–25.
Pleshkewych, A., Kramer, D. L., Kelly, E. & Porter, C. W., 1980. Cancer Res. 40: 4533–4540.
Atwell, G. J. & Cain, B. F., 1967. J. Med. Chem. 10: 706–713.
Denny, W. A., Atwell, G. J., Baguley, B. C. & Cain, B. F., 1979. J. Med. Chem. 22: 134–150.
Walls, L. P., 1963. Progr. Med. Chem. 3: 52–88.
Hansch, C., 1971. Chem. Rev. 71: 525–525
Atwell, G. J. & Cain, B. F., 1968. J. Med. Chem. 11: 295–300.
Atwell, G. J. & Cain, B. F., 1973. J. Med. Chem. 16:673–678.
Kensler, C. J., Palm, P. E., Day, H. M., Battista, S. P., Rogers, W. I. & Yesair, D. W., 1965. Cancer. Res. 25: 1622–1667.
Plowman, J. & Adamson, R. H., 1978. Pharmacology 17: 61–68.
Cain, B. F. & Atwell, G. J., 1976. J. Med. Chem. 19: 1417–1419.
Selsing, E., Wells, R. D., Alden, C. J. & Arnott, S., 1979. J. Biol. Chem. 254: 5417–5422.
Dattagupta, N., Hogan, M. & Crothers, D. M., 1978. Proc. Natl. Acad. Sci. U.S.A. 75: 4286–4290.
Gursky, G. V., Tumanyan, V. G., Zasedatelev, A. S., Zhuze, A. L., Grokhovsky, S. L. & Gottikh, B. P., 1976. Mol. Biol. Reports 2: 413–425.
Counsilman, A. C., Cain, B. F. & Baguley, B. C., 1974. Eur. J. Cancer 10: 75–81.
Counsilman, A. C., 1972. M. Sc Thesis, University of Auckland, New Zealand.
Robertson, I. G. C., 1978. Ph.D. Dissertation, University of Auckland, New Zealand.
Robertson, I. G. C., Denny, W. A. & Baguley, B. C., 1980. Eur. J. Cancer 16: 1133–1139.
Anderson, W. A., Boivin, J., Monneret, C. & Pais, M., 1980. Mutation Res. 72: 341–346.
Bénard, J. & Riou, G. F., 1980. Biochemistry 19: 4197–4201.
Nagley, P., Mattick, J. S., Hall, R. M. & Linnane, A. W., 1975. Mol. Gen. Genet. 141: 291–304.
Burchenal, J. H., Coley, V., Purple, J. R., Bucholz, E., Lyman, M. S. & Kreis, W., 1963. Cancer Res. 23: 1364–1374.
Kensler, C., 1963. Cancer Res. 23: 1353–1363.
Baguley, B. C. & Nash, R., 1981. Eur. J. Cancer 17: 671–679.
Loewe, H. & Urbanietz, J., 1974. Arzneim. Forsch. 24: 1927–1933.
Comings, D. E., 1978. Ann. Rev. Genet. 12: 25–46.
Patterson, J. S. & Battersby, L. A., 1980. Cancer Treat. Rep. 64: 775–778.
Furr, B. J., Patterson, J. S., Richardson, D. N., Slater, S. R. & Wakeling, A. E., 1979. In: Pharmacological and Biochemical Properties of Drug Substances (Goldberg, M. E., ed), vol. 2, A.P.A., Washington.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baguley, B.C. Nonintercalative DNA-binding antitumour compounds. Mol Cell Biochem 43, 167–181 (1982). https://doi.org/10.1007/BF00223008
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00223008